Patents by Inventor John P. Crow

John P. Crow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CB2 Receptor Modulators in Neurodegenerative Diseases and Applications of the Same
    Publication number: 20130303528
    Abstract: Compositions for the treatment of neurodegenerative diseases are disclosed. Methods of treating and monitoring progression of a neurodegenerative disease are disclosed. According to the present invention, a selective CB2 receptor modulator may be administered to a mammal for the treatment of a neurodegenerative disease.
    Type: Application
    Filed: March 29, 2013
    Publication date: November 14, 2013
    Inventors: Paul L. Prather, John P. Crow
  • CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same
    Publication number: 20090124608
    Abstract: Compositions for the treatment of neurodegenerative diseases are disclosed. Methods of treating and monitoring progression of a neurodegenerative disease are disclosed. According to the present invention, a selective CB2 receptor modulator may be administered to a mammal for the treatment of a neurodegenerative disease.
    Type: Application
    Filed: October 5, 2007
    Publication date: May 14, 2009
    Applicant: Board of Trustees of the University of Arkansas
    Inventors: Paul L. Prather, John P. Crow
  • Metalloporphyrin treatment of neurologic disease
    Patent number: 6372727
    Abstract: The present invention provides a method of treating amyotrophic lateral sclerosis and other neurologic diseases by administering a compound of the formula where R is selected from the group consisting of (C6H4)CO2H, (C6H4)CO2CH3, (C6H4)(3,5-OH)2, (C6H4)CH2OH, (C6H4)OCH3, (C6H4)PO3H, (C6H4)SO3H, (C6H4)(3-NO2-4-OH), (C6H4)NO2, (C6H4)OPO3H, (C6H4)OSO3H, (C6H4)CH2CO2H, (C6H4)NH2, and (C6H4)CONH2. Also provided is a method for preserving donor organs using a solution comprising the instant compounds.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: April 16, 2002
    Assignee: UAB Research Foundation
    Inventors: John P. Crow, Alvaro G. Estevez
  • Bathocuproine treatment of neurologic disease
    Patent number: 6022879
    Abstract: The present invention provides a method of treating amyotrophic lateral sclerosis and other neurologic diseases by administering bathocuproine or a related analog. Also provided are pharmaceutical compositions of bathocuproine.
    Type: Grant
    Filed: October 15, 1998
    Date of Patent: February 8, 2000
    Assignee: UAB Research Foundation
    Inventors: John P. Crow, Joseph S. Beckman